Geneva Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Geneva Advisors's LLY Position: Q2 2017 in Review
Geneva Advisors reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2017, selling an estimated $24.9K and leaving 19,937 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #266.
Geneva Advisors first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.76M in Q4 2015. 1,247 funds tracked by Wall St. Rank hold LLY as of Q2 2017.
- Geneva Advisors held 19,937 shares of Eli Lilly worth $1.64M as of Q2 2017.
- Geneva Advisors sold 305 Eli Lilly shares in Q2 2017, an estimated $24.9K.
- Eli Lilly made up 0.03% of Geneva Advisors's portfolio in Q2 2017, its #266 holding.
- Geneva Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
- Geneva Advisors's Eli Lilly position peaked at $1.76M in Q4 2015.
- 1,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.